MeSH term
Frequency | Condition_Probility | Comparative Study | 3 | 0.0 |
Genetic Predisposition to Disease/*genetics | 4 | 1.0 |
Humans | 50 | 0.0 |
Research Support, Non-U.S. Gov't | 44 | 0.0 |
Adolescent | 9 | 0.0 |
Child | 9 | 0.0 |
Diabetes Mellitus, Type 1/*genetics | 36 | 17.0 |
Female | 18 | 0.0 |
*Genomic Imprinting | 2 | 0.0 |
Insulin/*genetics | 17 | 27.0 |
Insulin-Like Growth Factor II/*genetics | 4 | 2.0 |
Male | 18 | 0.0 |
Sex Factors | 2 | 0.0 |
Adult | 10 | 0.0 |
Age of Onset | 2 | 0.0 |
Diabetes Mellitus, Type 1/epidemiology/*genetics | 4 | 18.0 |
Genome, Human | 4 | 0.0 |
Genotype | 13 | 0.0 |
HLA Antigens/genetics | 3 | 0.0 |
Linkage (Genetics)/*genetics | 2 | 0.0 |
Lod Score | 3 | 0.0 |
Nuclear Family | 2 | 0.0 |
Research Support, U.S. Gov't, P.H.S. | 11 | 0.0 |
Alleles | 19 | 0.0 |
Base Sequence | 4 | 0.0 |
Diabetes Mellitus, Type 2/genetics | 2 | 4.0 |
*Genetic Predisposition to Disease | 5 | 0.0 |
*Minisatellite Repeats | 5 | 6.0 |
Molecular Sequence Data | 6 | 0.0 |
Polymerase Chain Reaction | 5 | 0.0 |
*Polymorphism, Genetic | 4 | 0.0 |
Animals | 10 | 0.0 |
Chromosome Mapping | 11 | 0.0 |
Crosses, Genetic | 2 | 0.0 |
Rats | 2 | 0.0 |
Insulin/genetics | 5 | 16.0 |
Diabetes Mellitus, Type 1/*genetics/immunology | 3 | 5.0 |
Genetic Markers | 5 | 0.0 |
HLA Antigens/*genetics | 3 | 0.0 |
HLA-DQ Antigens/genetics | 5 | 1.0 |
HLA-DR Antigens/genetics | 4 | 1.0 |
Genetic Predisposition to Disease | 12 | 0.0 |
Haplotypes | 6 | 0.0 |
Major Histocompatibility Complex/genetics | 3 | 5.0 |
Polymorphism, Genetic | 8 | 0.0 |
Risk Factors | 3 | 0.0 |
Time Factors | 2 | 0.0 |
Minisatellite Repeats/*genetics | 3 | 4.0 |
Genetic Predisposition to Disease/genetics | 3 | 0.0 |
*Transcription, Genetic | 2 | 0.0 |
Diabetes Mellitus, Type 1/epidemiology/*etiology/genetics | 2 | 100.0 |
Major Histocompatibility Complex | 2 | 0.0 |
*Chromosome Mapping | 4 | 0.0 |
Chromosomes, Human, Pair 11 | 4 | 1.0 |
Minisatellite Repeats | 9 | 6.0 |
*Alleles | 2 | 0.0 |
Chromosomes, Human, Pair 6 | 2 | 1.0 |
Fathers | 2 | 3.0 |
*Linkage (Genetics) | 5 | 0.0 |
Mothers | 2 | 2.0 |
Pedigree | 3 | 0.0 |
Variation (Genetics) | 5 | 0.0 |
Middle Aged | 2 | 0.0 |
Gene Frequency | 4 | 0.0 |
*Gene Expression | 2 | 0.0 |
Polymorphism, Restriction Fragment Length | 3 | 0.0 |
Genes | 2 | 0.0 |
Incidence | 3 | 0.0 |
Disease Susceptibility | 7 | 0.0 |
Polymorphism, Genetic/genetics | 2 | 0.0 |
Case-Control Studies | 3 | 0.0 |
Child, Preschool | 6 | 0.0 |
*Immunoconjugates | 2 | 0.0 |
Infant | 4 | 0.0 |
Genome | 2 | 0.0 |
Mice | 4 | 0.0 |
*Chromosomes, Human, Pair 11 | 2 | 0.0 |
DNA Primers | 2 | 0.0 |
Insulin/*biosynthesis/*genetics | 2 | 50.0 |
RNA, Messenger/biosynthesis | 2 | 0.0 |
Graves' Disease/genetics | 2 | 25.0 |
Gene Expression | 2 | 0.0 |
Haplotypes/genetics | 2 | 0.0 |
Insulin-Like Growth Factor II/genetics | 2 | 2.0 |
European Continental Ancestry Group | 2 | 0.0 |
Risk Assessment | 2 | 0.0 |
Finland | 2 | 0.0 |
Polymorphism, Single Nucleotide/genetics | 2 | 0.0 |
Linkage (Genetics) | 3 | 0.0 |
Genomic Imprinting | 2 | 1.0 |
Linkage Disequilibrium | 2 | 0.0 |
Mice, Inbred NOD | 2 | 0.0 |
DNA, Satellite/genetics | 2 | 1.0 |
Genetic Screening | 2 | 0.0 |
